GPX3 and gastric adenocarcinoma: Overall, patients with high GPX3 expression and low GPX3 expression in COAD, PRAD, KIRC, LUAD, and STAD showed differences in T-, N-, and M-stage, lymph node metastasis, and occurrence of recurrence.